Award
National Cancer Institute 5R01CA262555-05
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
Recipient
Washington University
Award Amount
$653,623.00
Ceiling
$653,623.00
Awarded
September 05, 2025
Identifier
5R01CA262555-05
Research grant awarded by the National Cancer Institute to Washington University for developing predictive biomarkers for recurrence in triple-negative breast cancer, with a focus on immune and tumor cell bone marrow biomarkers.
Description
This is a research grant opportunity focused on breast cancer, immunotherapy, and biomarkers. The project aims to understand immune microenvironment and develop predictive biomarkers for recurrence in triple-negative breast cancer. The project involves extensive biorepository analysis and clinical trials.